ETHANOLAMINE HYDROCHLORIDE
Molecular Excipient
| Mwt. | LogP | HBD | HBA | PSA | RB | CSP3 |
|---|---|---|---|---|---|---|
| 61.0 | -1.1 | 2 | 2 | 46.0 | 1 | 1.0 |
- CAS
- 2002246
- UNII
- KKP3YYL02F
- SYNONYMS
-
- ZINC ID(s)
- Availability
- Present in 73 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has been an intervention in the following clincial trials (per clinicaltrials.gov).
| Code | Date | Title | Phase | Status |
|---|---|---|---|---|
| NCT02071901 | 2014-08-01 | Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy | Phase 2 | Recruiting |
| NCT01772420 | 2012-10-01 | Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome | Phase 2 | Recruiting |
| NCT01610180 | 2012-06-01 | Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs) | Phase 2 | Recruiting |
| NCT01550185 | 2012-05-01 | Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia | Phase 1 | Recruiting |
| NCT01830660 | 2012-04-01 | A Phase I Study of Hetrombopag Olamine in Healthy Adult Volunteers | Phase 1 | Recruiting |
| NCT01139749 | 2011-10-01 | Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea | Phase 4 | Recruiting |
| NCT01147809 | 2010-06-01 | Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag | Phase 2 | Active, Not Recruiting |
| NCT01098487 | 2010-05-01 | A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP) | Phase 4 | Completed |
| NCT00990587 | 2009-10-01 | Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy | Phase 1 | Active, Not Recruiting |
| NCT00903422 | 2009-05-01 | Eltrombopag Treatment of Thrombocytopenia in Subjects With Advanced Myelodysplastic Syndrome (MDS) or Secondary Acute Myeloid Leukemia After MDS (sAML/MDS) | Phase 1 | Completed |
| NCT01173965 | 2008-01-01 | Endometrial Ablation With Non-hysteroscopic Methods | Phase 4 | Completed |
| NCT00351468 | 2006-06-01 | EXTEND (Eltrombopag Extended Dosing Study) | Phase 3 | Active, Not Recruiting |
| NCT00802672 | 2003-12-01 | Safety and Equivalence of a Generic Ciclopirox Olamine Cream Compared to the Reference Ciclopirox Cream 0.77% for the Treatment of Tinea Pedis | Phase 3 | Completed |